303 Clinical and laboratory associations of longitudinal cell-bound complement activation products i...
303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE
About this item
Full title
Author / Creator
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
IntroductionCell-bound complement activation products (CB-CAPs) in a multi-analyte assay with algorithm (MAP) is a valuable biomarker for the diagnosis of SLE. Erythrocyte-bound complement activation products have been associated with SLE disease activity. The clinical and serologic phenotype of longitudinal MAP positive patients has not been well...
Alternative Titles
Full title
303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7b6de56cd9bd4ed289aa6cbc46f3bab8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b6de56cd9bd4ed289aa6cbc46f3bab8
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2023-lupus21century.16
